Olmesartan Medoxomil
Olimestra belongs to a group of medicines called angiotensin II receptor antagonists. It lowers blood pressure by relaxing blood vessels.
Olimestra is used to treat high blood pressure (hypertension) in adults and in children and adolescents from 6 to less than 18 years of age. Hypertension can cause damage to blood vessels in organs such as the heart, kidneys, brain, and eyes. In some cases, this may lead to heart attack, heart or kidney failure, stroke, or blindness.
Hypertension usually does not cause any symptoms. Monitoring blood pressure allows preventing these damages.
Hypertension can be controlled by taking medications such as Olimestra. To help lower blood pressure, your doctor may also recommend lifestyle changes (e.g., weight loss, stopping smoking, reducing alcohol consumption, and reducing salt intake in your diet). Your doctor may also encourage you to engage in regular physical activity, such as walking or swimming.
It is essential to follow your doctor's advice.
Before taking Olimestra, discuss it with your doctor or pharmacist.
Tell your doctorif you are taking any of the following medicines for high blood pressure:
Your doctor may recommend regular monitoring of kidney function, blood pressure, and electrolyte levels (e.g., potassium) in your blood.
See also the section "When Not to Take Olimestra".
Tell your doctor if you have any of the following health problems:
If you experience severe, persistent diarrhea that causes significant weight loss, contact your doctor. Your doctor will assess your symptoms and decide how to continue your blood pressure treatment.
If you experience stomach pain, nausea, vomiting, or diarrhea after taking Olimestra, discuss it with your doctor. Your doctor will decide on further treatment. Do not stop taking Olimestra on your own.
As with any blood pressure-lowering medicine, excessive lowering of blood pressure in patients with impaired blood flow to the heart or brain may lead to heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
You must inform your doctor about pregnancy, suspected pregnancy, or planning to become pregnant. It is not recommended to take Olimestra during early pregnancy. You must not take Olimestra after the third month of pregnancy, as it may seriously harm your baby (see section "Pregnancy").
Studies have been conducted on the use of olmesartan medoxomil in children and adolescents. For more information, contact your doctor. Olimestra is not recommended for children under 6 years of age. Olimestra should not be used in children under 1 year of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take:
Elderly Patients
In patients over 65 years of age, whose dose is increased to 40 mg per day, your doctor will recommend regular monitoring of blood pressure to ensure that it does not drop too much.
Black Patients
As with similar medicines, the blood pressure-lowering effect of Olimestra may be slightly less in black patients.
Olimestra can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
You must inform your doctor about pregnancy, suspected pregnancy, or planning to become pregnant. Your doctor will usually recommend stopping Olimestra before you become pregnant or as soon as you know you are pregnant and will prescribe another medicine. It is not recommended to take Olimestra during early pregnancy. You must not take Olimestra after the third month of pregnancy, as it may seriously harm your baby.
Breastfeeding
Inform your doctor about breastfeeding or intending to breastfeed. It is not recommended to take Olimestra while breastfeeding. Your doctor may choose another medicine if you intend to breastfeed, especially if you are breastfeeding a newborn or premature baby.
During treatment for high blood pressure, you may occasionally experience drowsiness or dizziness. In such cases, do not drive or operate machinery until these symptoms have resolved. Consult your doctor.
If you know you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The recommended starting dose is 10 mg once daily. If blood pressure control is not adequate, your doctor may increase the dose to 20 mg or 40 mg once daily or prescribe additional medications.
The recommended starting dose is 10 mg once daily. If blood pressure control is not adequate, your doctor may increase the dose to 20 mg or 40 mg once daily. In children with a body weight below 35 kg, the dose should not exceed 20 mg once daily.
In patients with mild to moderate kidney disease, the dose should not exceed 20 mg once daily.
Tablets can be taken with or without food. Swallow the tablet with a sufficient amount of liquid (e.g., a glass of water). If possible, take the medicine at the same time each day, e.g., during breakfast.
If you have taken more than the recommended dose of Olimestra or if a child has accidentally taken Olimestra, seek medical advice immediately and take the package with you to the hospital or doctor.
If you forget to take a dose, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
It is important to continue taking Olimestra for as long as your doctor recommends.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Olimestra can cause side effects, although not everybody gets them.
Although rare, the following side effects may be serious:
Rarely (may affect up to 1 in 1000 people), the following allergic reactions have been reported:
During treatment with Olimestra, facial swelling, mouth and/or throat swelling with itching and rash may occur. If you experience these symptoms, stop taking Olimestra and contact your doctor immediately.
Rarely (but more frequently in elderly people), Olimestra may cause excessive lowering of blood pressure in sensitive individuals or as a result of an allergic reaction. This may lead to severe dizziness or fainting. If you experience these symptoms, stop taking Olimestra, contact your doctor immediately, and lie down.
Frequency not known: if you experience yellowing of the whites of the eyes, dark urine, itching of the skin, even if you have been taking Olimestra for a long time, contact your doctor immediately, who will assess your symptoms and decide how to continue your blood pressure treatment.
Other known side effects of Olimestra include:
Common side effects (may affect up to 1 in 10 people):
Dizziness, headache, nausea, indigestion, diarrhea, stomach pain, gastritis, fatigue, sore throat, runny nose or stuffy nose, bronchitis, flu-like symptoms, cough, pain, chest pain, back pain, bone or joint pain, urinary tract infections, swelling of the ankles, feet, legs, hands, or arms, blood in the urine.
Abnormal laboratory test results have also been reported:
Increased levels of fats (hypertriglyceridemia), increased levels of uric acid (hyperuricemia), increased levels of urea in the blood, increased activity of liver and muscle enzymes.
Uncommon side effects (may affect up to 1 in 100 people):
Anaphylactic reactions (severe allergic reactions that can affect the whole body and cause difficulty breathing, as well as a sudden drop in blood pressure that can lead to fainting), vertigo, vomiting, weakness, malaise, muscle pain, skin rash, allergic dermatitis, itching, hives (skin eruptions), skin bumps (blisters), angina pectoris (chest pain or discomfort).
Abnormal laboratory test results have also been reported, including a decrease in the number of blood cells called platelets (thrombocytopenia).
Rare side effects (may affect up to 1 in 1000 people):
Lack of energy, muscle cramps, kidney problems, kidney failure, intestinal angioedema: swelling in the intestine with symptoms such as stomach pain, nausea, vomiting, and diarrhea.
Abnormal laboratory test results have also been reported, including increased levels of potassium (hyperkalemia) and increased levels of substances related to kidney function.
In children, side effects are similar to those reported in adults.
However, dizziness and headache are more common in children, while nosebleeds are a common side effect that occurs only in children.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special storage precautions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
10 mg: white, round, slightly convex film-coated tablets with "S1" engraved on one side; tablet diameter: 6.5 mm.
20 mg: white, round, slightly convex film-coated tablets with "S2" engraved on one side; tablet diameter: 8 mm.
40 mg: white, oval, convex film-coated tablets with "S3" engraved on one side; tablet dimensions: 13 mm x 8 mm.
Packaging: 28, 30, 56, or 60 film-coated tablets in blisters in a cardboard box.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8000 Novo mesto, Slovenia
Date of Last Revision of the Leaflet:20.03.2025
Member State | Marketing Authorization Holder |
Bulgaria | Olimestra 10/20/40 mg film-coated tablets |
Denmark | Olimesta |
Estonia | Olimestra 10/20/40 mg |
Latvia | Olmesartan Krka 10/20/40 mg apvalkotās tabletes |
Lithuania | Olimestra 10/20/40 mg plėvele dengtos tabletės |
Poland | Olimestra |
Romania | Olimestra 10/20/40 mg comprimate filmate |
Slovakia | Olimestra 10/20/40 mg filmom obalené tablety |
Slovenia | Olimestra 10/20/40 mg filmsko obložene tablete |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.